Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pilomatrical carcinosarcoma in the very elderly: A case report.

Molecular and clinical oncology·2021

Same author

A case of high-grade mucinous tubular and spindle cell carcinoma.

Journal of surgical case reports·2020

Same author

An Autopsy Case of Rupture of Infectious Thoracic Aortitis Induced by Methicillin-Resistant Staphylococcus Aureus.

The American journal of case reports·2019

Same author

Malignant rhabdoid tumour in an adult kidney: A case report.

Molecular and clinical oncology·2019

Same author

Extra-gastrointestinal stromal tumor with a large cyst.

Journal of surgical case reports·2019

Same author

Large-cell neuroendocrine carcinoma arising in the endometrium: A case report.

Molecular and clinical oncology·2018

Search research articles

Related Experiment Video

Updated: Jul 11, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

Innovative BMT methods for intractable diseases.

Susumu Ikehara¹

¹First Department of Pathology, Transplantation Center, Regeneration Research Center for Intractable Diseases, Center for Cancer Therapy, Kansai Medical University, Moriguchi City, Osaka 570-8506, Japan. ikehara@takii.kmu.ac.jp

Immunologic Research

|October 6, 2007

Summary

New bone marrow transplantation (BMT) methods, including perfusion collection and intra-bone marrow injection, minimize T cell contamination, preventing graft-versus-host disease (GvHD) and enhancing engraftment for various diseases.

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Related Experiment Videos

Last Updated: Jul 11, 2026

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Hydrogel Arrays Enable Increased Throughput for Screening Effects of Matrix Components and Therapeutics in 3D Tumor Models

Published on: June 16, 2022

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Area of Science:

Transplantation immunology
Regenerative medicine
Hematology

Background:

Intractable diseases require innovative treatment strategies.
Conventional bone marrow transplantation (BMT) faces challenges like T cell contamination and graft-versus-host disease (GvHD).
Existing methods may lead to graft failure, especially with reduced radiation doses in organ allografts.

Purpose of the Study:

To establish novel bone marrow transplantation (BMT) methods for treating intractable diseases.
To improve the safety and efficacy of BMT by minimizing T cell contamination and preventing GvHD.
To explore the potential of new BMT techniques in regeneration therapy and age-associated diseases.

Main Methods:

Perfusion method (PM) for collecting bone marrow cells (BMCs), minimizing T cell contamination.
Intra-bone marrow (IBM)-BMT for direct injection of whole BMCs into the bone marrow cavity.
Utilizing BMCs containing both hemopoietic stem cells (HSCs) and mesenchymal stem cells (MSCs) for enhanced engraftment.

Main Results:

PM minimizes T cell contamination, preventing GvHD without T cell removal.
IBM-BMT facilitates hemopoietic cell engraftment and prevents graft failure in organ allografts, even with reduced radiation.
IBM-BMT supports regeneration therapy for age-associated diseases like osteoporosis by recruiting donor-derived MSCs.
Combined IBM-BMT with donor lymphocyte infusion (DLI) prevents GvHD and suppresses tumor growth.

Conclusions:

New BMT methods, PM and IBM-BMT, offer a revolutionary approach to transplantation and regeneration therapy.
IBM-BMT enhances engraftment, prevents GvHD, and has broad applications in treating various diseases.
This strategy holds significant promise for the future of BMT, organ allografts, and regenerative medicine.